These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 16364577)

  • 41. Quantitative assessment of the switchability of generic products.
    Karalis V; Bialer M; Macheras P
    Eur J Pharm Sci; 2013 Nov; 50(3-4):476-83. PubMed ID: 23981332
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Transdermal drug transport and metabolism. II. The role of competing kinetic events.
    Potts RO; McNeill SC; Desbonnet CR; Wakshull E
    Pharm Res; 1989 Feb; 6(2):119-24. PubMed ID: 2762211
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Percutaneous absorption and metabolism of 2-butoxyethanol in human volunteers: a microdialysis study.
    Korinth G; Jakasa I; Wellner T; Kezic S; Krüse J; Schaller KH
    Toxicol Lett; 2007 Apr; 170(2):97-103. PubMed ID: 17412532
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacokinetic analysis of bioequivalence trials: implications for sex-related issues in clinical pharmacology and biopharmaceutics.
    Chen ML; Lee SC; Ng MJ; Schuirmann DJ; Lesko LJ; Williams RL
    Clin Pharmacol Ther; 2000 Nov; 68(5):510-21. PubMed ID: 11103754
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Bioequivalence for topical products--an update.
    Narkar Y
    Pharm Res; 2010 Dec; 27(12):2590-601. PubMed ID: 20859663
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bioequivalence of two lansoprazole delayed release capsules 30 mg in healthy male volunteers under fasting, fed and fasting-applesauce conditions: a partial replicate crossover study design to estimate the pharmacokinetics of highly variable drugs.
    Thota S; Khan SM; Tippabhotla SK; Battula R; Gadiko C; Vobalaboina V
    Drug Res (Stuttg); 2013 Nov; 63(11):551-7. PubMed ID: 23780504
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A three-step procedure for assessing bioequivalence in the general mixed model framework.
    Vuorinen J; Turunen J
    Stat Med; 1996 Dec; 15(24):2635-55. PubMed ID: 8981677
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Percutaneous absorption of salicylates from some commercially available topical products containing methyl salicylate or salicylate salts in rats.
    Megwa SA; Benson HA; Roberts MS
    J Pharm Pharmacol; 1995 Nov; 47(11):891-6. PubMed ID: 8708981
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Saliva vs. plasma bioequivalence of paracetamol in humans: validation of class I drugs of the salivary excretion classification system.
    Idkaidek N; Arafat T
    Drug Res (Stuttg); 2014 Oct; 64(10):559-62. PubMed ID: 24452519
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Model-based analyses of bioequivalence crossover trials using the stochastic approximation expectation maximisation algorithm.
    Dubois A; Lavielle M; Gsteiger S; Pigeolet E; Mentré F
    Stat Med; 2011 Sep; 30(21):2582-600. PubMed ID: 21793036
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Is there tissue penetration after application of topical salicylate formulations?
    Cross SE; Anderson C; Thompson MJ; Roberts MS
    Lancet; 1997 Aug; 350(9078):636. PubMed ID: 9288049
    [No Abstract]   [Full Text] [Related]  

  • 52. Percutaneous absorption of salicylic acid after repeated (14-day) in vivo administration to normal, acnegenic or aged human skin.
    Davis DA; Kraus AL; Thompson GA; Olerich M; Odio MR
    J Pharm Sci; 1997 Aug; 86(8):896-9. PubMed ID: 9269866
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dermal PK/PD of a lipophilic topical drug in psoriatic patients by continuous intradermal membrane-free sampling.
    Bodenlenz M; Höfferer C; Magnes C; Schaller-Ammann R; Schaupp L; Feichtner F; Ratzer M; Pickl K; Sinner F; Wutte A; Korsatko S; Köhler G; Legat FJ; Benfeldt EM; Wright AM; Neddermann D; Jung T; Pieber TR
    Eur J Pharm Biopharm; 2012 Aug; 81(3):635-41. PubMed ID: 22554768
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Percutaneous penetration of felbinac after application of transdermal patches: relationship with pharmacological effects in rats.
    Shinkai N; Korenaga K; Takizawa H; Mizu H; Yamauchi H
    J Pharm Pharmacol; 2008 Jan; 60(1):71-6. PubMed ID: 18088507
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bioequivalence of two enteric coated formulations of pantoprazole in healthy volunteers under fasting and fed conditions.
    de Campos DR; Vieira NR; Bernasconi G; Barros FA; Meurer EC; Marchioretto MA; Coelho EC; Calafatti SA; Sommer C; Couto JM; Buranello S; Silva AR; Amarante AR; Abib E; Júnior JP
    Arzneimittelforschung; 2007; 57(6):309-14. PubMed ID: 17688075
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prediction of concentration-time profile and its inter-individual variability following the dermal drug absorption.
    Polak S; Ghobadi C; Mishra H; Ahamadi M; Patel N; Jamei M; Rostami-Hodjegan A
    J Pharm Sci; 2012 Jul; 101(7):2584-95. PubMed ID: 22517028
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Bioequivalence evaluation of two brands of amoxicillin/clavulanic acid 250/125 mg combination tablets in healthy human volunteers: use of replicate design approach.
    Idkaidek NM; Al-Ghazawi A; Najib NM
    Biopharm Drug Dispos; 2004 Dec; 25(9):367-72. PubMed ID: 15495146
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A preliminary model to avoid the overestimation of sample size in bioequivalence studies.
    Ramírez E; Abraira V; Guerra P; Borobia AM; Duque B; López JL; Mosquera B; Lubomirov R; Carcas AJ; Frías J
    Drug Res (Stuttg); 2013 Feb; 63(2):98-103. PubMed ID: 23427051
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Bioequivalence evaluation of two formulations of pidotimod using a limited sampling strategy.
    Huang JH; Huang XH; Wang K; Li JC; Xie XF; Shen CL; Li LJ; Zheng QS
    Biomed Pharmacother; 2013 Jul; 67(6):475-80. PubMed ID: 23639228
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Determining bioequivalence of topical dermatological drug products by tape-stripping.
    Navidi W; Hutchinson A; N'Dri-Stempfer B; Bunge A
    J Pharmacokinet Pharmacodyn; 2008 Jun; 35(3):337-48. PubMed ID: 18465213
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.